MINNEAPOLIS, May 20, 2013 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI) announced today that it will release financial results for the fiscal fourth quarter and full year ended March 31, 2013 at the market close on Thursday, May 30, 2013. The Company will host a conference call and webcast to discuss these results on Thursday, May 30, 2013 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). Individuals wishing to participate in the conference call should dial 888-549-7750, no passcode is necessary. To access the live webcast of the call, go to Uroplasty's website at www.uroplasty.com and click on Investor Relations.
An audio replay will be available for 30 days following the call at 800-406-7325 with the passcode 4618943#. An archived webcast will also be available at www.uroplasty.com.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a global medical company committed to offering transformative treatment options to specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.
Medi Jiwani, Vice President, CFO, and Treasurer
Jenifer Kirtland (Investors)
Amy Phillips (Media)
SOURCE Uroplasty, Inc.
Help employers find you! Check out all the jobs and post your resume.